foxo4-dri senolytic 2023 2024 study

foxo4-dri senolytic 2023 2024 study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells ES2 rapidly destroys TP53-FOXO4 foci

Name: foxo4-dri senolytic 2023 2024 study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells ES2 rapidly destroys TP53-FOXO4 foci
Brand: iglepidom.org
SKU: 74462355843
Price: 28.39 USD
Availability: InStock
Rating: 4.756 (16 reviews)

ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC Senescence Inducers and Senolytics Pathways and Drugs Targeting Cellular Senescence[v1] Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 74462355843 · From iglepidom.org

4.8

USD28.39 USD51.39

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Safety Considerations and Protocol Modifications Common Side Effects and Management While epithalon generally demonstrates excellent tolerability in research settings, some subjects may experience mild effects during protocol implementation